Copyright
©The Author(s) 2018.
World J Transplant. Feb 24, 2018; 8(1): 13-22
Published online Feb 24, 2018. doi: 10.5500/wjt.v8.i1.13
Published online Feb 24, 2018. doi: 10.5500/wjt.v8.i1.13
Table 2 Immunosuppressive and other therapies in both groups
| Tacrolimus | Cyclosporine | Steroid therapy | Purine synthesis inhibitors | (mTOR) inhibitors | Anti-hypertensive therapy | Beta-blockers | Insulin therapy | Statin | Ezetimibe | |
| Group A, n = 44 | 28 (64%) | 12 (27%) | 35 (80%) | 33 (75%) | 7 (16%) | 33 (75%) | 18 (14%) | 1 (2%) | 14 (34%) | 2 (5%) |
| Group B, n = 41 | 27 (66%) | 10 (24%) | 30 (73%) | 34 (83%) | 5 (12%) | 30 (73%) | 18 (44%) | 2 (5%) | 18 (41%) | 2 (5%) |
- Citation: Roi GS, Mosconi G, Totti V, Angelini ML, Brugin E, Sarto P, Merlo L, Sgarzi S, Stancari M, Todeschini P, La Manna G, Ermolao A, Tripi F, Andreoli L, Sella G, Anedda A, Stefani L, Galanti G, Di Michele R, Merni F, Trerotola M, Storani D, Nanni Costa A. Renal function and physical fitness after 12-mo supervised training in kidney transplant recipients. World J Transplant 2018; 8(1): 13-22
- URL: https://www.wjgnet.com/2220-3230/full/v8/i1/13.htm
- DOI: https://dx.doi.org/10.5500/wjt.v8.i1.13